Darya Chudova - May 3, 2023 Form 3 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Stock symbol
GH
Transactions as of
May 3, 2023
Transactions value $
$0
Form type
3
Date filed
5/15/2023, 05:42 PM
Next filing
Sep 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GH COMMON STOCK 12.4K May 3, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GH RESTRICTED STOCK UNITS May 3, 2023 COMMON STOCK 41.6K $0.00 Direct F1, F2
holding GH STOCK OPTION (RIGHT TO BUY) May 3, 2023 COMMON STOCK 4.33K $4.66 Direct F3
holding GH STOCK OPTION (RIGHT TO BUY) May 3, 2023 COMMON STOCK 17.5K $8.80 Direct F4
holding GH STOCK OPTION (RIGHT TO BUY) May 3, 2023 COMMON STOCK 17.4K $94.47 Direct F5
holding GH STOCK OPTION (RIGHT TO BUY) May 3, 2023 COMMON STOCK 10.1K $117.61 Direct F6
holding GH STOCK OPTION (RIGHT TO BUY) May 3, 2023 COMMON STOCK 42.9K $47.20 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units consist of five grants totalling 41,597 shares outstanding as of May 3, 2023. The first grant was granted on August 1, 2019, of which 1,440 shares are outstanding, and will vest on August 1, 2023. The second grant was granted on September 11, 2020, of which 5,817 shares are outstanding, and vests 25% on the remaining two year anniversary of September 9, 2021. The third grant was granted on November 4, 2020, of which 9,756 shares are outstanding, and vests in full on November 4, 2024. The fourth grant was granted on November 2, 2021, of which 3,157 shares are outstanding, and vests in equal quarterly installments on the anniversary or 9/1/2022 over the next two and a half years. The fifth grant was granted on November 7, 2022, of which 21,427 shares are outstanding, and vests 25% on October 1, 2023 and the remaining vests in equal quarterly installments over the remaining three-year period thereafter.
F2 Not applicable for Restricted Stock Units.
F3 The stock option vests and becomes exercisable in equal monthly installments over 24 months commencing on December 31, 2019.
F4 The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018.
F5 The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 1, 2019.
F6 This represents a stock option granted on November 2, 2021 that vests over a four-year period. 25% of the shares subject to such award vests on September 1, 2022 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter.
F7 This represents a stock option granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter.